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Abstract
Using atomic force microscopy (AFM) we investigated the interaction of amyloid beta (Ab) (1–42) peptide with chemically
modified surfaces in order to better understand the mechanism of amyloid toxicity, which involves interaction of amyloid
with cell membrane surfaces. We compared the structure and density of Ab fibrils on positively and negatively charged as
well as hydrophobic chemically-modified surfaces at physiologically relevant conditions. We report that due to the complex
distribution of charge and hydrophobicity amyloid oligomers bind to all types of surfaces investigated (CH3, COOH, and
NH2) although the charge and hydrophobicity of surfaces affected the structure and size of amyloid deposits as well as
surface coverage. Hydrophobic surfaces promote formation of spherical amorphous clusters, while charged surfaces
promote protofibril formation. We used the nonlinear Poisson-Boltzmann equation (PBE) approach to analyze the
electrostatic interactions of amyloid monomers and oligomers with modified surfaces to complement our AFM data.
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Introduction
Amyloid fibrils are implicated in many neurodegenerative
diseases for which no cure is currently available, including
Alzheimer’s (AD), Huntington’s and Parkinson’s diseases [1–5].
Despite the differences in the native structures and functions of the
amyloid forming proteins, they form similar fibrils irrespective of
the protein from which they originate [4,5]. The molecular
mechanism of amyloid toxicity is not well understood. The
proposed mechanism of amyloid fibril formation involves protein
cleavage from the membrane, unfolding and formation of amyloid
fibrils [6]. Although fibril plaque formation is associated with
biological membranes in vivo, the role of membrane surfaces is not
well understood. A growing number of recent research contribu-
tions suggest the importance of membrane surfaces [4,7–16] and
in particular the role of electrostatic interactions between the lipid
membrane and amyloid-forming proteins [17–19]. Therefore, the
detailed investigation of amyloid fibril formation on the surface of
lipid membrane is extremely important and may provide an
insight into understanding the mechanism of amyloid fibril
formation and toxicity. While biological surfaces are extremely
important in protein adsorption and amyloid fibril formation,
interpreting the results of heterogeneous and complex systems like
plasma membranes is often very difficult. Chemically modified
surfaces with well-defined physical properties can be considered as
simplified models to study the effect of surfaces on amyloid binding
and fibril formation. The study of protein aggregation on surfaces
has recently attracted a lot of attention [12,20–24] and grown even
more important due to the increased use of inorganic and
synthetic surfaces as interfaces in bio- and nano-technology.
It has become evident that surfaces play a crucial role in
amyloid fibril formation for many amyloidogenic peptides. The
size and shape of amyloid aggregates and fibrils, as well as the
kinetics of their formation are affected by the physicochemical
nature of the surface. It has been shown that for many amyloid
peptides, fibril formation is accelerated significantly by surfaces
when compared to fibrillization in solution [24,25]. In addition to
catalyzing the rate of fibril formation, the mechanism of
fibrillization on surfaces has been shown to be different from that
in solution [24].
Although it has been shown that the surfaces play an important
role in amyloid fibril formation, electrostatic interaction cannot be
easily compared as often experiments presented by different
research groups are done at varying experimental conditions, such
as pH, temperature, the type of surfaces and the type of peptide
used. Protein binding to surfaces at high temperatures cannot be
compared to experiments on surfaces conducted at room
temperatures [26], nor can different experiments done at different
pH [26–31] be compared to elucidate the effect of surfaces. This
comparison is also difficult due to the limited type of surfaces used
[24] for the same type of amyloid proteins [25,26]. Therefore,
more work is required to understand the effect of surface
functionality using simple model surfaces before moving to more
complex surfaces of lipid bilayer or plasma membrane. Our
hypothesis is that the surface charge and hydrophobicity affects
the structure, amount and surface coverage of Ab deposits and
may play an important role when interactions of Ab with cell
surfaces are considered. To make a clear comparison these
surfaces need to be compared under the same conditions in order
to elucidate their effect on Ab aggregation. Recently Wang et al
PLoS ONE | www.plosone.org 1 October 2011 | Volume 6 | Issue 10 | e25954[32,33] reported a systematic molecular dynamics study on Ab
binding to self-assembled thiol monolayers with four different
functional groups.
In our experiments using high resolution atomic force
microscopy we studied the interaction of Ab (1–42) with three
different surfaces: positively charged (NH2), negatively charged
(COOH) and hydrophobic (CH3) modified surfaces at pH 7.8, at
37uC, in order to determine the effect of these surfaces on amyloid
aggregation and fibril formation. In order to understand
electrostatic interactions of amyloid aggregates with functionalized
surfaces we employed the nonlinear Poisson-Boltzmann equation
(PBE) approach [34]. Using this methodology [34–38], it has been
demonstrated recently that electrostatic potentials can be success-
fully calculated for large micromolecules and bioassemblies, which
helps to understand the function of these structures. We used the
PBE approach to analyze the interactions of amyloid monomers
and oligomers with thiol-modified surfaces and compared these to
AFM data. To the best of our knowledge, this is a first report
where electrostatic interactions of Ab peptide and oligomers were
compared in similar experimental conditions, combining experi-
mental AFM data and PBE theoretical analysis.
Results and Discussion
Amyloid plaques are formed when proteins which exist in an
alpha-helical form, unfold, convert to beta-sheets and form fibrils.
Amyloid fibril formation has been studied extensively in solution
where the interaction between peptide molecules is mainly
considered. According to the proposed hypothesis, interaction
between amyloidogenic peptides in solution may result in the
formation of various aggregates, such as small oligomers and long
fibrils with twisted morphology [3,39] which are formed by
attaching monomer units to the end of growing fibrils. However,
the structure of protofibrils formed on the surface is different from
the twisted morphology of fibrils formed in solution [25,40,41].
The proposed mechanism includes two distinct stages: nucleation
and elongation [25,40–44]. According to this model, aggregation
of amyloid peptides on surfaces occurs via formation of small
oligomeric units. Bidirectional elongation of so-called protofibrils
on the surface occurs with the addition of monomers, oligomeric
building blocks, or smaller protofibrils. Investigation of these
oligomers is of high importance as they recently have been
recognized to interact actively with the cell surfaces inducing more
toxic effects [45–48] than mature Ab fibrils, as it was assumed
earlier [49–52]. The size of these oligomeric units depends on the
type of the protein and may correspond to monomer, dimer, or
small oligomer, or, in some cases, may include up to 20–100
individual peptide molecules [25,40,44].
Time Dependence.
We investigated fibril formation of Ab (1–42) peptide on
chemically modified surfaces bearing CH3, COOH, and NH2
functional groups. A progressive accumulation of Ab deposits with
time was observed on all surfaces. Figure 1 shows the increase of
amyloid fibril formation with time on an NH2-modified surface. At
10 minutes incubation (Figure 1A) mostly small spherical aggre-
gates and a few small protofibrils were observed on the surface.
After 6 hours incubation (Figure 1B), both small spherical
aggregates and a growing number of protofibrils were observed.
After 22 hours incubation (Figure 1C), fibrils grow in size and
form larger clusters of longer fibrils and small oligomers. These
amyloid clusters vary from 20–70 nm in height, and fibrils are
500 nm to 2 mm long, 4 nm or 6–8 nm high. Underneath the
larger clusters, the surface is covered with small spherical
aggregates approximately 2 nm high. These small spherical
aggregates were visible on the surfaces at all incubation times. A
similar increase in size and amount of aggregation was observed
on two other functionalized surfaces, as shown in Figure 1.
Effect of Surfaces
Although all surfaces promoted adsorption of similar smaller
building blocks, we observed that the CH3-modified surface
promoted formation of amorphous aggregates, while hydrophilic
NH2- and COOH-modified surfaces showed clusters of small
spheres and short protofibrils (Figure 2). Figure 2 shows the AFM
topography images of amyloid deposits formed after 22 hours
incubation on CH3-terminated surface (Figure 2A), NH2-termi-
nated surface (Figure 2B), and COOH-terminated surface
(Figure 2C).
Each of these surfaces after 22 hours incubation show large
clusters of Ab aggregates. The hydrophobic CH3-terminated
surface (Figure 2A) shows amorphous globular clusters of various
sizes joined together, but no long separated fibrils were observed
on this surface. Both the positively charged NH2-surface
(Figure 2B) and negatively charged COOH-surface (Figure 2C)
show clusters of fibril-like structures and uniformly sized globular
aggregates. We found that smaller spherical aggregates cover the
surface uniformly in between larger clusters (Figure 2 B and C),
forming a monolayer which covers the surface completely
underneath larger clusters. The density of larger clusters is highest
on CH3-modified surface (Figure 2A) and lowest on NH2-modified
surface (Figure 2B). We performed a statistical analysis of
aggregate surface coverage at 22 hours incubation, counting for
the second layer of amyloid deposits formed. The CH3-modified
surface is covered by amyloid deposits almost completely (94%
surface coverage), whereas the COOH- and NH2-modified are
Figure 1. AFM topography images (10610 mm) of amyloid fibril formation on NH2- modified surfaces: (A) after 10 minutes, (B) after
6 hours, and (C) after 22 hours incubation at 376C in HEPES buffer, pH 7.8.
doi:10.1371/journal.pone.0025954.g001
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23.7% respectively (Figure 2).
High resolution images, Figure 3, show clearly that the first
monolayer on each surface type is composed of smaller aggregates
densely packed together. This monolayer is formed after 1 hour
incubation. At 1 hour incubation we also can clearly see few small
and separated protofibrils, formed on the top of the monolayer,
Figure 3 A, B, C, D, and G. These protofibrils are also composed
of spherical aggregates, as shown on Figure 3C, similar in size to
the monolayer components.
The shape and size of small oligomers were slightly different
for different surfaces. Figure 3C, 3F, and 3I show small scan areas
of the monolayer for each surface type. Figure 4 shows results of
statistical analysis of size distribution. Both surface area and
height plots indicate that the negatively charged COOH-
modified surface (Figure 4 C and D) and positively charged
NH2-modified surface (Figure 4 E and F) have smaller aggregates
than the CH3–modified surface (Figure 4 A and B). The Ab
oligomers on the hydrophobic CH3–modified surface are mostly
spherical and less uniform in size, which is revealed by broad
Figure 2. AFM topography images (565 mm) of the amyloid fibrils formed on CH3,N H 2, and COOH –modified surfaces. Aß peptide
solution was incubated for 22 hours at 37uC on: (A) CH3-, (B) NH2-, and (C) COOH-modified surfaces.
doi:10.1371/journal.pone.0025954.g002
Figure 3. High resolution images of AFM topography of Aß aggregates formed on modified surfaces: CH3- (A–C), COOH- (D–F), and
NH2- (G–I) modified surfaces, after incubation with Ab (1–42) solution (500 mg/ml) for 1 hour at 376C.
doi:10.1371/journal.pone.0025954.g003
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NH2 and COOH surfaces.
The presence of small oligomeric units correlates with
previously reported oligomer building blocks [39] for Ab (1–40).
The authors [39–41] observed spherical units of Ab (1–40) of
varying dimensions immediately following the initiation of
fibrillization. It has been shown that stable oligomers of a range
of molecular weights of both Ab (1–40) and Ab (1–42) were
isolated from brain and synthetic amyloid material. Size-exclusion
chromatography of Ab deposits has previously revealed dimeric
(9 kDa) and trimeric (13.5 kDa) forms [39,53] whereas incubation
of monomeric Ab has led to the separation of 4-, 19-, and 46-kDa
fragments [54]. Others also reported the presence of oligomer
units [53,55,56].
Although we observed small oligomers present on all types of
surfaces used, interestingly, these smaller building blocks on the
COOH-terminated surface were not spherical, but rather
triangular. This may be a result of the interaction with the
negatively charged COOH surface. The aggregates making up the
monolayer on the NH2 surfaces were also not completely
spherical, but resemble a triangular shape. They appear to be a
similar shape to the COOH surface, but more tightly packed
together. This indicates that electrostatic interactions with the
surfaces may affect the oligomer folding and packing and therefore
the shape of the smaller building blocks. Small size triangular
shaped oligomers were not observed before, but were proposed by
simulations of trimer structures by Paravastu et al. 2008 [57]
versus spherical – dimer structures. Wang et al [32] also has shown
by molecular dynamics simulations that Ab is relatively free to
move at the CH3 surfaces but stick to COOH- and NH2-surfaces,
which may result in more ordered appearance of Ab deposits on
charged surfaces, compared to CH3-surfaces [32].
The electrostatic interactions between the charged surfaces and
Ab directly influence the structure of formed amyloid deposits and
may affect the secondary structure of amyloid in these clusters.
These electrostatic interactions can be understood when we
consider complex charge distribution in Ab peptide and its
dependence on secondary structure. There are six negatively
charged residues and three positively charged residues in the
peptide, yielding a net charge of -3, with isoelectric point of about
5.5 [58]. Figure 5 demonstrates the organization of charge within
various peptide secondary structures. For the a-helix structure
(Figure 5A), the charge is fairly evenly distributed to prevent a
dipole from forming. In the case of a b-sheet (Figure 5B), a strong
positively charged region (blue) forms on either side of peptide,
and the negatively charged (red) regions are dispersed through the
remainder of the peptide. However, when several b-sheets are
stacked together (Figure 5C), strong charged regions form within
the aggregate creating a quadrupole moment. Therefore, based on
this analysis, we expect that a-helical peptides preferentially form
on the hydrophobic CH3 surface, and b-sheet clusters of various
sizes on the negatively charged COOH and positively charged
NH2 surfaces.
Our findings at neutral pH correlate with work by McMasters
et al [27], where the authors investigated amyloid fibril formation
of Ab peptide on chemically modified mica bearing positively or
negatively charged, or hydrophobic functional groups at pH 11.5.
Using reflection-absorption infrared spectroscopy, the authors
found that surfaces covered with sulfonic acid, carboxylic acid,
alcohol, and trifluoro-terminated thiol monolayers all cause
Figure 4. Statistical analysis of Aß small aggregates shown in figure 3. Histograms of aggregate unit area size (A, C, E) and height of each
aggregate (B, D, F) for each surface type; (Red) CH3-modified surface; (green) COOH-modified surface; (blue) NH2-modified surface.
doi:10.1371/journal.pone.0025954.g004
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composed of peptides in beta-sheet, beta-turn, random coil and
a -helical conformation. The CF3 monolayer study revealed that
equilibrium is slightly shifted towards an a-helix form. This
correlates with our results showing amorphous aggregates, in a-
helix form and no fibrils on the CH3-modified surfaces. Our
observation is consistent also with findings by Giacomelli et al
[28], who used spectroscopy methods and showed that adsorption
of Ab (1–40) (at pH 7 and 10, at 25uC) on both hydrophobic
Teflon and hydrophilic silica solid surfaces causes conformational
changes of the adsorbed peptide, inhibiting polymerization, which
occurs in solution during incubation. The conformation of the
peptide strongly depends on the hydrophobicity of the surface:
hydrophobic interactions promote intramolecular a-helix forma-
tion, whereas electrostatic interactions promote intermolecular b-
sheet formation. In addition to different structures, we showed that
surface-mediated aggregation occurs faster for CH3-modified and
COOH-modified surfaces as compared to NH2-modified surfaces.
This is indicated by larger amyloid surface coverage for CH3-
modified surface and COOH-modified surface shown on Figure 2.
In addition our analysis of electrostatic potential distribution
using PBE shows that surface charge distribution is different in Ab
monomer, dimer or larger oligomers. Oligomers in b-sheet
conformations show larger collective polarity, which induces
stronger electrostatic interactions with surfaces, as well as
preferential ordering on the oligomers on the surfaces. This may
be the driving force for more ordered and fibril-like structures
observed on charged surfaces, compared to CH3-modified
surfaces. Electrostatic forces induced by surfaces may also drive
the re-distribution of electrostatic potential in monomers near the
surfaces and therefore may change the secondary structure of the
peptide, thus inducing electrostatically driven amyloid fibril
formation.
Incubation of Amyloid Peptide in Solution
We observed that protofibrils formed on surfaces are composed
of small spherical units, branched and can grow in any direction
by adding the spherical building blocks. Unlike protofibrils formed
on surfaces (Figure 3) which are composed of small spheres, fibrils
formed in solution (Figure 6) are long, continuous and twisted
together into helices, and do not reveal any bead-like structure.
This correlates with previously reported data by Blackley et al
[40]. The smaller spherical building blocks were not commonly
observed in our experiments for fibrils formed in solution
(Figure 6), and we rarely observed twisting of protofibrils formed
on the surfaces. This suggests that the unfolding of the oligomer
units in order to form twisted fibrils is hindered by the surfaces. In
solution the peptides have more degrees of freedom (such as
rotational, translational, and protein folding), whereas on the
surface the degrees of freedom are significantly limited. Addition-
ally, once a peptide is bound to the surface, the peptide has likely
found an energy minimum, and therefore requires an energy input
to overcome the potential well. Gibbs free energy decreases as a
result of the protein absorbing to the surface, and therefore energy
must be given to the protein to overcome this decrease [59]. This
is consistent with the molecular dynamics simulations data [60,61],
Figure 5. Electrostatic potentials of amyloid monomers and oligomers. The 5kT and -5kT isoelectric potential surfaces are superimposed on
the molecular surface. Positive charge is shown in blue, and negative in red. The molecular surface is produced by convolving a 1.4A ˚ sphere (which
represents a water molecule) around each peptide. The (A) alpha helix monomer does not have any strongly charged regions, whereas the (B) beta
sheet monomer has a strong positively charged end. In comparison, the (C) stack of 5 beta sheets has 4 strongly charged regions, which would
greatly contribute to electrostatic interactions with charged surfaces. Images were produced using PyMOL v1.2.
doi:10.1371/journal.pone.0025954.g005
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it is very unlikely for the chain to fold into ordered b-sheet
structures. It is much more common for the chains to fold into
amorphous aggregates which are in dynamic equilibrium.
Conclusions
We investigated the interaction of Ab (1–42) peptide with three
different chemically modified surfaces and compared the effect of
these surfaces at the same physiologically relevant conditions. We
found that due to the complex dipole distribution amyloid
oligomers bind to all surface types investigated (-CH3, -COOH,
and -NH2) although the size and shape of these amyloid deposits
depend on surface properties. Hydrophilic surfaces show proto-
fibrils coexisting with spherical oligomer aggregates, while
hydrophobic CH3-modified surfaces cause formation of amor-
phous spherical aggregates. The surface charge and hydrophobic-
ity define both the structure of the fibril aggregates formed on the
surfaces and kinetics of their accumulation. In addition our
analysis of electrostatic potential distribution using PBE shows that
surface charge distribution changes depending on the secondary
structure of the peptide and may play an important role in
electrostatically driven amyloid fibril formation on surfaces.
Materials and Methods
Chemicals and Sample Preparation
Decanethiol, 3-mercaptoethanol, APTES (3-Aminopropyl-
triethoxysilane) and HEPES buffer were purchased from Aldrich
Chemical Co. HPLC grade ethanol was purchased from Sigma.
All chemicals were used as received. Water used for sample
preparation was purified (distilled de-ionized, millipore water).
Substrate Preparation
Atomically flat gold on mica surfaces were purchased from
Agilent Technologies, Inc. (Santa Clara, CA). These gold surfaces
were affixed to clean glass cover slips using Epo-Tek 377 glue from
Epo-Tek, Inc. (Billerica, MA), which was cured at 150uC for 1
hour. The gold glued to the glass was peeled from the mica,
revealing the atomically flat gold surface. The gold surfaces were
further modified by incubating in an appropriate 5 mM thiol
solution in ethanol for 48 hours. Prepared mica-gold substrates
were modified with decanethiol and 3-mercaptoethanol, and pure
glass substrates were modified with APTES.
Amyloid Peptide Preparation and Incubation
Ab (1–42) was purchased freeze-dried in 0.5 mg vials from
rPeptide (Atlanta, GA). These amyloid samples were pretreated
according to the Fezoui et al. (2000) procedure [62] to ensure
monomeric solution. After this each 0.5 mg aliquot was dissolved
in 1 mL of pH 7.8 50 mM HEPES buffer. Small amount of the
protein solution (50 mL aliquots) were immediately placed on
modified surface and were incubated at 37uC in liquid cell. After
defined period of time (from 10 min to 22 hours) samples were
rinsed with millipore DI water, dried with gentle stream of
nitrogen, and kept in a desiccator prior to imaging.
AFM Imaging and Analysis
Imaging was done in intermittent contact mode on a JPK
Nanowizard II atomic force microscope (AFM) recorded with
AC mode, and on an Agilent AFM/SPM-5500 AFM using MAC
mode imaging. Images were obtained with Nanoworld NCH
tips, with a resonant frequency of 338 kHz and 42 N/m spring
constant in air or Agilent MAC mode cantilevers, with a
resonant frequency of 75 kHz and a spring constant of 2.8 N/m
in air.
Statistical analysis was done with the program called CellPro-
filer. The shape of each amyloid aggregate was measured using
image recognition. The purpose of the program is to count the
number of spherical aggregates (or cells) in an image. Using this
program we determined the size and shape of the aggregates. The
Figure 6. AFM topography images of Ab (1–42) incubated in solution (500 mg/mL concentration) at 376C for 22 hours. After
incubation, 10 mL of solution was deposited onto cleaved mica for 5 minutes, followed by rinsing with nanopure water and drying with a gentle
nitrogen stream. A 10610 mm scan area (A) of the surface shows many fibrils ranging from 0.1 – 4 mm. (B) High resolution image (5006500nm)
demonstrates that fibrils reveal twisted morphologies, characteristic of formed in solution; (below, left) expanded view of region enclosed by white
box in (B) with optimized z-scale; (below, right) height profile along fibril axis clearly demonstrating maxima and minima which is characteristic of the
twisted morphology.
doi:10.1371/journal.pone.0025954.g006
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543 for COOH, and 245 for NH2 surfaces.
Electrostatic Modeling
Electrostatic potentials of Ab monomers in b-sheet and a-helix
conformations, and amyloid oligomers were obtained by solving
the Adaptive Poisson-Boltzmann Solver (APBS v1.2.1b) [35,63]
implementation for PyMol v1.2. Briefly, the APBS method uses
the finite element method to numerically solve the nonlinear
Poisson-Boltzmann equation, representing the electrostatic inter-
actions between molecules in aqueous environments [34]. We
constructed surface potential profiles for Ab monomers in b-sheet
and a-helix conformations and amyloid pentamers based on
crystalline structure obtained from protein data bank [64,65].
The electrostatic interaction energies are calculated for each
voxel within a defined volume. In our calculations the solvent
dielectric constant was 80, and the protein dielectric was
approximated as 2.0. The isoelectric potential of 5kT and -5kT
was mapped onto the A-b monomers and beta sheet oligomer.
The monomers and oligomers are displayed by convolving a 1.4A ´
sphere representing the approximate solvent size.
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